Note 12. Derivative Instruments

9 Months Ended

Mar. 31, 2019

Derivative Instruments and Hedging Activities Disclosure

Derivative Instruments

We hold a total investment of $2.0 million in a privately-held company, including $1.5 million in stock warrants. The investment in stock warrants is accounted for as a derivative instrument and is included in the Other Assets line of the Condensed Consolidated Balance Sheets. The stock warrants are convertible into equity shares of the privately-held company upon achieving certain milestones. The value of the stock warrants will fluctuate primarily in relation to the value of the privately-held company's underlying securities, either providing an appreciation in value or potentially expiring with no value. During the quarter ended March 31, 2019, the change in fair value of the stock warrants was not significant. See Note 10 - Fair Value in the Notes to Condensed Consolidated Financial Statements for more information on the valuation of these securities. Information on the location and amounts of derivative fair values in the Consolidated Balance Sheets are presented below.

All foreign exchange contracts were settled as of the quarter ended March 31, 2019.



Fair Values of Derivative Instruments on the Condensed Consolidated Balance Sheets
	Asset Derivatives					Liability Derivatives
		Fair Value As of					Fair Value As of
(Amounts in Thousands)	Balance Sheet Location	March 31 2019		June 30 2018		Balance Sheet Location	March 31 2019		June 30 2018
Derivatives designated as hedging instruments:
Foreign exchange contracts						Accrued expenses	$	—	$	10

Derivatives not designated as hedging instruments:
Stock warrants	Other Assets	$	1,500	$	1,500
Total derivatives		$	1,500	$	1,500		$	—	$	10